New insights could help prevent peripheral neuropathy or slow disease onset
An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.
Scientific American13d
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Morningstar8d
Hands On Diagnostics Study Finds A Groundbreaking Approach to Treating Neuropathy with the NeuFit NEUBIE Device
The multi-site clinical trial finds significant improvements in pain, sensation, and nerve signaling. "Neuropathy is incredibly common among the aging population, regardless of disease states.
Managed Healthcare Executive13d
FDA Approves Journavx, New Nonopioid Med, for Acute Pain
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...
BioSpace7d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Edzard Ernst1d
“Tuina therapy is a safe and effective treatment option” – but there are many good reasons for disbelieving this statement
Tuina, or Tui Na is based on the notion that imbalances of the life-force, qi, can cause blockages or imbalances that lead to symptoms and illness. Tuina massage is similar to acupressure in that it ...
FiercePharma3d
British biotech rebrands as Octavian, seeking to establish new empire after setbacks in 2024
Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...
GlobalData on MSN8d
USPTO grants patent to Vistagen’s neuropathic pain treatment
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
OCT Holdings Announces Rebrand to Octavian Therapeutics, Appointment of New Chair and Fundraising Launch
Octavian Therapeutics ("Octavian" or "the Company"), a leading clinical-stage innovator in neuropathic pain treatment, today announces a transformative rebrand, the appointment of a new Non-Executive ...